tirzepatide and parkinson's disease How a drug used to treat might affect the brain Dual GLP‑1 and GIP Agonist

For microdosing protocols , some researchers add 2.5 mL to a 5 mg vial, creating a 2 mg/mL solution

Whilst it does not directly treat diabetic neuropathy, its ability to improve glycaemic control and support weight loss may indirectly reduce the risk of developing nerve damage or slow its progression

Pharmacists should advise patients on the potential for dehydration and to take precautions to avoid fluid depletion by maintaining adequate fluid intake of sugar-free fluids and, if unwell, following their usual sick day rules (advice for managing the condition during concurrent illness)

It modulates dopamine and serotonin turnover in key regions (striatum, frontal cortex, hippocampus), contributing to the observed nootropic and antidepressant effects